About Jeanne Jones
Jeanne Jones is a seasoned Senior Clinical Project Manager with over 25 years of diverse experience in clinical research, spanning site, CRO, and sponsor perspectives, and has held leadership roles in several prominent healthcare organizations.
Known information
Jeanne Jones has amassed over 25 years of experience in the field of clinical research, demonstrating expertise from various perspectives including site, CRO, and sponsor. She began her career with a Bachelor of Science in Nursing from the University of Iowa, followed by a Master of Science in Nursing and Administration from the University of Nebraska in Omaha. Jeanne has worked on all phases of clinical trials, from Phase I to III, across different sectors of the industry. Her roles have included Senior Project Manager for various clinical and device trials, Vice President of Clinical Operations at Mary Crowley Cancer Research, and Senior Director of Clinical Operations for Oncology at Genzyme. At US Oncology, she escalated from Senior Director to Vice President of Development, where she developed and managed strategic partnerships with multiple large pharmaceutical companies. Jeanne also provided oversight to over 100 early phase clinical trials at Mary Crowley, working with over 50 pharmaceutical companies and CROs. Her leadership was instrumental in leading a global team to the completion of a phase III trial for subjects with Chronic Lymphocytic Leukemia (CLL) and a pivotal phase II trial in multiple sclerosis at Genzyme. Additionally, she has significantly contributed to the expansion of clinical sites and the development of clinical trial portfolios, particularly in oncology.
About AOA Dx
AOA Dx, headquartered in New York, NY, and Cambridge, MA, is a healthcare company specializing in early cancer detection technologies, particularly focusing on ovarian cancer through innovative blood tests like GlycoLocate™ and AKRIVIS GD™.